When Nicole DuFresne was killed in New York in 2005, the media twisted the narrative by latching onto a phrase that fell out ...

Sam Bennett could have gone to free agency and picked his landing spot, plus probably could have signed for much more money than the Florida Panthers were able to offer.

CLEVELAND, Ohio – Actor and playwright Molly McFadden – whose life has been touched by Alzheimer’s disease – will present her one-woman play about the illness and participate in a post ...

Alzheimer’s disease, a progressive neurodegenerative disease that causes decreased memory and cognitive function, affects more than 7 million people in the U.S. alone.

Joe Thomas is The Daily Signal’s Virginia correspondent. He is a 37-year broadcasting veteran with 17 years covering Virginia from the marches to the memorials and everything in between. With ...

June is Alzheimer’s and Brain Awareness Month. More than 7 million Americans ages 65 and older are living with Alzheimer’s disease right now, according to the Alzheimer’s Association.

Researchers at the University of California San Diego School of Medicine have developed a gene therapy for Alzheimer's disease that could help protect the brain from damage and preserve cognitive ...

Two jobs are linked to a lower Alzheimer's risk. Even if you do a different kind of work or are retired, these jobs show how to keep your mind sharp.

ATLANTA — New data shows that there are more people living with Alzheimer’s Disease than ever before. Channel 2’s Linda Stouffer spoke with a doctor about the urgent effort to get people to ...

New data reveals more than 7 million Americans are currently living with Alzheimer’s – a first in U.S. history. Experts warn this number is projected to nearly double, reaching an estimated 14 ...

An annual review of clinical trials for Alzheimer's disease highlights a growing number of active trials—and drugs—in the development pipeline and offers optimism for the global effort to find ...

Between 1995 and 2021 private money spent on Alzheimer’s research came to $42.5bn, but more than 140 trials failed to yield a single drug capable of slowing the disease. Yet the tide may be turning.